Scott A. Van Wart
- Pharmacology top 2%
- Molecular Medicine top 1%
- Infectious Diseases top 5%
- Epidemiology top 10%
- Clinical Biochemistry top 5%
- Co-authors
- Paul G. AmbroseSujata M. BhavnaniAlison MeagherBrenda CirincioneDaniel K. ReynoldsChristopher M. RubinoJulie PassarellEvelyn J. Ellis‐Grosse
- Topics
- Antibiotics Pharmacokinetics and Efficacy (20 papers)Pneumonia and Respiratory Infections (11 papers)Antibiotic Resistance in Bacteria (9 papers)
- Partner nations
- United StatesUnited KingdomSpain
In The Last Decade
Scott A. Van Wart
33 papers receiving 869 citations
Peers
Comparison fields: 5 of 85
- Pharmacology 548
- Molecular Medicine 353
- Infectious Diseases 349
- Epidemiology 324
- Clinical Biochemistry 114
Countries citing papers authored by Scott A. Van Wart
This map shows the geographic impact of Scott A. Van Wart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott A. Van Wart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott A. Van Wart more than expected).
Fields of papers citing papers by Scott A. Van Wart
This network shows the impact of papers produced by Scott A. Van Wart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott A. Van Wart. The network helps show where Scott A. Van Wart may publish in the future.
Co-authorship network of co-authors of Scott A. Van Wart
This figure shows the co-authorship network connecting the top 25 collaborators of Scott A. Van Wart. A scholar is included among the top collaborators of Scott A. Van Wart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott A. Van Wart. Scott A. Van Wart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 2 | |
| 4 | 19 | |
| 5 | 21 | |
| 6 | 19 | |
| 7 | 11 | |
| 8 | 27 | |
| 9 | 27 | |
| 10 | 19 | |
| 11 | 20 | |
| 12 | 17 | |
| 13 | 13 | |
| 14 | 83 | |
| 15 | 17 | |
| 16 | 42 | |
| 17 | 69 | |
| 18 | 13 | |
| 19 | 26 | |
| 20 | 84 |
About Scott A. Van Wart
Scott A. Van Wart is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Pharmacology, having authored 33 papers that have together received 901 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (20 papers), Pneumonia and Respiratory Infections (11 papers) and Antibiotic Resistance in Bacteria (9 papers). The work is most often cited by research in Molecular Medicine (353 citations), Applied Microbiology and Biotechnology (110 citations) and Pharmacology (548 citations). Scott A. Van Wart has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Paul G. Ambrose, Sujata M. Bhavnani, Alison Meagher, Brenda Cirincione, Daniel K. Reynolds, Christopher M. Rubino, Julie Passarell, Evelyn J. Ellis‐Grosse, David R. Andes and Timothy Babinchak. Their work appears in journals such as Blood, Antimicrobial Agents and Chemotherapy and Science Translational Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.